Patents Assigned to Hiroyuki Nawa
  • Publication number: 20060167026
    Abstract: The purpose of this invention is to provide an agent useful for prevention and/or treatment of psychosis, schizophrenia and cognitive impairments. To solve this problem, this invention provides epidermal growth factor receptor inhibitors as therapeutic agents for psychosis, schizophrenia and cognitive impairments.
    Type: Application
    Filed: January 5, 2004
    Publication date: July 27, 2006
    Applicant: Hiroyuki Nawa
    Inventors: Hiroyuki Nawa, Makoto Mizuno